Trial · NCT04005352
Outcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Distribution of the Last Interval With no Disease Activity up to Week 32 - Study Eye | Up to Week 32 | Full Analysis Set (Includes participants who were randomized and treated.) | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Average Change From Baseline at Week 28 and Week 32 in Best-corrected Visual Acuity (BCVA) - Study Eye | Baseline, Week 28 and Week 32 | Full Analysis Set - Last observation carried forward (LOCF). | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Distribution of the Last Interval With no Disease Activity up to Week 64 - Study Eye | Up to Week 64 | Full Analysis Set | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Distribution of the Maximal Intervals With no Disease Activity up to Week 64 - Study Eye | Up to Week 64 | Full Analysis Set | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With no Disease Activity - Study Eye | Weeks 14 and 16 | Full Analysis Set. Note that the number analyzed is reduced because the Week 14 visit was conducted at the investigator's discretion, and because some patients had already stopped treatment by Week 16. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Time From Last Loading Injection to First Visit With No Disease Activity (Weeks) - 75th Percentile - Study Eye | Up to Week 64 | Full Analysis Set - subjects with no important protocol deviations with impact | weeks | NUMBER |
| SECONDARY | Time-to-first Dry Retina - Time to the First Visit With no Intraretinal Fluid (IRF) or Subretinal Fluid (SRF) - Study Eye | Up to Week 64 | Full Analysis Set - subjects with no important protocol deviations with impact | Participants | NUMBER |
| SECONDARY | Average Change From Baseline at Week 60 and Week 64 in Best-corrected Visual Acuity (BCVA) - Study Eye | Baseline, Week 60 and Week 64 | Full Analysis Set - LOCF | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Number of Participants With Best-corrected Visual Acuity Improvements of ≥ 15 Letters in BCVA From Baseline or Reached BCVA ≥ 84 Letters up to Week 32/64 Per Treatment Arm - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set - LOCF | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Best-corrected Visual Acuity ≥ 69 Letters - Study Eye | Week 32 and Week 64 | Full Analysis Set - LOCF | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Average Change From Baseline in Central Subfield Thickness (CSFT) - Study Eye | Baseline, Weeks 28 and 32 and at Weeks 60 and 64 | Full Analysis Set - LOCF | micrometers | LEAST_SQUARES_MEAN |
| SECONDARY | Number of Participants With Presence of Intraretinal Fluid and/or Subretinal Fluid in the Central Subfield - Study Eye | At Weeks 28, 32, 60 and 64 | Full Analysis Set | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Presence of Sub-Retinal Pigment Epithelium Fluid in the Central Subfield - Study Eye | At Weeks 28, 32, 60 and 64 | Full Analysis Set | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Change From Baseline in Visual Function Questionnnaire-25 (VFQ-25) - Composite Scores - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Visual Function Questionnnaire-25 (VFQ-25) - Subscale Score - General Vision - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Visual Function Questionnnaire-25 (VFQ-25) - Subscale Score - Ocular Pain - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline n Visual Function Questionnnaire-25 (VFQ-25) - Subscale Score - Near Activities - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Visual Function Questionnnaire-25 (VFQ-25) - Subscale Score - Distance Activities - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Visual Function Questionnnaire-25 (VFQ-25) - Subscale Score - Social Functioning - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set | Scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Visual Function Questionnnaire-25 (VFQ-25) - Subscale Score - Mental Health - Study Eye | Baseline, Week 32, and Week 64 | Full Analysis Set | Scores on a scale | LEAST_SQUARES_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04005352/outcomes